SCLC-A cell lines had a broad spectrum of sensitivity to PT: high expression of SLFN11 in SCLC-A cell lines correlated with high sensitivity to both cisplatin and PARPi. The gene discussed is SLFN11; the disease is small cell lung carcinoma.